ArticleMicrobial cell factories2026
Discovery of a dimeric isopimarane derivative by reexploring a labdane-related diterpenoid biosynthetic gene cluster in Aspergillus nidulans.
Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundDiterpenes derived from geranylgeranyl diphosphate include the pimarane family, a class of tricyclic diterpenoids widely distributed in plants and fungi. Previous studies on Aspergillus nidulans identified a biosynthetic gene cluster containing a diterpene cyclase that produces ent-pimara-8(14),15-diene, whereas subsequent biochemical analysis suggested the enzyme instead generates an isopimarane scaffold.
resultsIn this study, we have reexplored this diterpene biosynthetic pathway by using a multi-cluster deletion strain to reduce the metabolite background and a modified version of the highly inducible alcA promoter system to drive expression of a transcription factor in the cluster that includes the diterpene cyclase gene. The transcription factor, in turn, drives expression of all the genes of the cluster. Induction of expression resulted in production of compounds not seen with prior methods. Liquid chromatography-mass spectrometry (LC-MS) and Nuclear magnetic resonance (NMR) analysis has enabled us to identify dipleosmarane (3), a new dimeric isopimarane derivative, together with six known isopimarane diterpenoids (1, 2, 4a, 4b, 5, 6). Gene deletion experiments targeting the terpene cyclase (pbcA) and geranylgeranyl pyrophosphate synthase (pbcB) confirmed that these metabolites originate from this cluster.
conclusionsOur findings support the conclusion that the A. nidulans diterpene cyclase primarily synthesizes an isopimarane scaffold rather than an ent-pimarane derivative. Furthermore, the combination of transcription factor activation and a multi-cluster deletion background proved effective for revealing previously undetected metabolites from this pathway. These findings provide new insight into fungal diterpenoid biosynthesis and establish a useful platform for further genetic dissection and engineering of isopimarane biosynthetic pathways in Aspergillus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.